Well I take issue on the very first line of the Reason article "Trade restrictions and over-zealous FDA regulation are a big part of the problem, but there's more."
The plant is closed with bacterial infection problems linked to the deaths of two infants. That seems the opposite of over-zealous FDA regulation.
There are definitely other regulatory issues, but I would characterize them as regulatory capture - too little regulation going against corporate interests.
Temporary easing of trade restrictions does seem like a good thing, but not really permanent easing as I suspect Reason would prefer. Permanent easing leads us to even bigger supply insecurity risks imho.
The plant is closed with bacterial infection problems linked to the deaths of two infants. That seems the opposite of over-zealous FDA regulation.
There are definitely other regulatory issues, but I would characterize them as regulatory capture - too little regulation going against corporate interests.
Temporary easing of trade restrictions does seem like a good thing, but not really permanent easing as I suspect Reason would prefer. Permanent easing leads us to even bigger supply insecurity risks imho.